Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 2Thoracic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 1328Carcinoma, Hepatocellular 782Stomach Neoplasms 720Pancreatic Neoplasms 701Colonic Neoplasms 533Rectal Neoplasms 472Esophageal Neoplasms 422Liver Neoplasms 320Neoplasms 264Breast Neoplasms 221Lung Neoplasms 188Gastrointestinal Neoplasms 164Cholangiocarcinoma 150Barrett Esophagus 116Prostatic Neoplasms 107Neoplasm Metastasis 105Ovarian Neoplasms 89Carcinoma, Non-Small-Cell Lung 80Anus Neoplasms 77Melanoma 72Esophageal Squamous Cell Carcinoma 71Disease 71Head and Neck Neoplasms 70Colorectal Neoplasms, Hereditary Nonpolyposis 67Biliary Tract Neoplasms 67Gastrointestinal Stromal Tumors 66Liver Cirrhosis 60Gallbladder Neoplasms 58Recurrence 57Uterine Cervical Neoplasms 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Nervous System Neoplasms × Gastrointestinal × Clear all
NCT01236053 2017-07-06

Cancer in Patients With Gabapentin (GPRD)

GlaxoSmithKline

Completed
2,323,608 enrolled 86 charts
BreastGastrointestinalGenitourinaryThoracic

Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Diabetes Mellitus, Epilepsy, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Nervous System Neoplasms, Neuralgia, Pancreatic Neoplasms, Penile Neoplasms, Stomach Neoplasms, Pancreatitis, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡